ADP ribose polymerase inhibitors for treating non-small cell lung cancer: new additions to the pharmacotherapeutic armamentarium
2020
ABSTRACTIntroduction: Poly (ADP-ribose) polymerase inhibitors (PARPi) are already part of the armamentarium of drugs available against ovarian and breast cancer. There is less data available on the...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
58
References
2
Citations
NaN
KQI